Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11974754 Systems and methods for treating aneurysms
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
April 5, 2021
0
Date of Patent
May 7, 2024
0
Patent Application Number
17222092
0
Patent Citations
US Patent 8333796 Embolic coil implant system and implantation method
0
US Patent 9585670 Exclusion device and system for delivery
0
US Patent 9597087 Filamentary devices for treatment of vascular defects
0
US Patent 9636117 Devices, systems and methods for enclosing an anatomical opening
0
US Patent 9669188 Noncircular inner lumen guiding catheter with assisted variable support
0
US Patent 9855052 Devices and methods for the treatment of vascular defects
0
US Patent 9918720 Multiple layer filamentary devices for treatment of vascular defects
0
US Patent 9980733 System for and method of treating aneurysms
0
US Patent 10111670 Expandable vascular occlusion device with lead framing coil
0
US Patent 10123805 Space filling devices
0
•••
Patent Inventor Names
Thomas J. Wolfe
0
Arturo Rosqueta
0
Edgard Luiz Ramos Pereira
0
Aamir Badruddin
0
Brett Follmer
0
Osama O. Zaidat
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11974754
0
Patent Primary Examiner
Vi X Nguyen
0
CPC Code
A61F 2/01
0
A61B 17/00234
0
A61B 17/12031
0
A61B 17/12172
0
A61B 17/12
0
A61B 17/12113
0
A61B 17/12177
0
A61B 2017/00867
0
A61F 2/013
0
A61B 17/00
0
Find more entities like US Patent 11974754 Systems and methods for treating aneurysms
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE